Clinical Trial Update: Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting the completed Phase 2/3 study of AdoMet (S-adenosyl-L-methionine) and Betaine for chronic hepatitis C patients who did not respo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• AdoMet (S-adenosyl-L-methionine)
• Betaine (betaine (trimethylglycine))

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED